CM Hospitalar SA

CM Hospitalar SA has a liquidity ratio of 1.33, indicating a moderate level of liquidity, with a debt-to-equity ratio of 2.0, suggesting a significant reliance on debt financing. The company's return on equity is 0.94%, and return on assets is 0.2%, both of which are below the industry average, indicating suboptimal profitability and asset utilization. The company's operating income is 531,663,000 BRL, with a net income of 18,239,000 BRL, reflecting a narrow margin. The gross profit of 1,668,940,000 BRL is also relatively low compared to its revenue of 11,566,926,000 BRL, suggesting that the company is facing competitive pressures or cost inefficiencies. CM Hospitalar SA operates throughout Brazil, with a commercial and logistical structure. The company's revenue is concentrated in the domestic market, with no significant international exposure. The company's strategy includes the acquisition of companies from the segment and commercial strengthening throughout Brazil, which may lead to increased revenue concentration. The company's revenue is expected to grow, with a current FY outlook of 5% and a next FY outlook of 7%. The company's operating cash flow is 276,580,000 BRL, and free cash flow is 183,085,000 BRL, indicating a positive cash flow position. However, the company's capital expenditure is -165,526,000 BRL, suggesting a reduction in investment. The company faces a medium liquidity risk, with a current ratio of 1.33 and a debt-to-equity ratio of 2.0. The risk assessment indicates a low dilution risk, with a dilution potential of 0.0. The company's key flags include negative net cash after subtracting total debt, which may impact its financial stability. Recent events include analyst estimates with a mean price target of 1.46 BRL and a median price target of 1.40 BRL. The mean recommendation is 3.14, with no strong-buy recommendations and one buy recommendation. The company's market price is 1.31 BRL, with a market cap of 413,708,883.48 BRL.